Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

General Research Article

Clinical and Morphological Evaluation of Erosive and Ulcerative Gastric Lesions in Patients with Rheumatoid Arthritis

Author(s): Vladimir Beloglazov, Andrey Petrov, Vitalii Kaliberdenko, Kseniya Abramova and Kulanthaivel Shanmugaraj*

Volume 18, Issue 1, 2023

Published on: 18 October, 2022

Page: [46 - 55] Pages: 10

DOI: 10.2174/1574887117666220513102512

Price: $65

conference banner
Abstract

Background: One of the most important problems associated with the treatment of Rheumatoid Arthritis (RA) is erosive-ulcerative lesions (EUL) of the gastroduodenal zone, which is associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs).

Aims: Our research aims to study the clinical and histo-morphological criteria for forming the EUL of the gastroduodenal zone in patients with RA.

Methods: Patients were divided into 3 groups, depending on the presence of an EUL, according to Fibrogastroduodenoscopy (FGDS) data with a negative test for H. pylori. Group 1 included RA patients without EUL (n = 18), group 2 RA patients with erosive lesions of the gastroduodenal zone (n = 57), and group 3 consisted of RA patients with ulcerative lesions (n = 17). As a norm, we used data from a survey of 18 healthy donors corresponding to RA patient’s age and sex distribution, where no somatic pathology was revealed. GSRS questionnaire was used for assessment of subjective symptoms. For histomorphological studies, biopsy specimens were taken during FGDS using an Olympus Evis Exera II digital video endoscope.

Results: Patients of RA with EUL in the gastro-duodenal zone were significantly different from the group of healthy donors and patients of group 1 by the severity of 5 symptoms related to the upper gastrointestinal tract according to the GSRS questionnaire, including abdominal pain, heartburn, belching acid, a feeling of sucking and burning in epigastria, nausea and vomiting. In general, there were no clinically significant differences between the frequency of occurrence and the severity of symptoms on the GSRS scale between group 2 and group 3, except for complaints of heartburn. So, RA patients of group 3 had a higher rate of heartburn feeling of 3.0 (2.0-3.0) points than patients of group 2 with 2.0 (1.0-2.0) points.

Conclusion: The development of a EUL of the gastroduodenal zone in patients with RA is associated with low activity of inflammation in all studied slides, regardless of structurally destructive changes in the stomach and duodenum and compensatory hyperplastic reactions in the superficial layer of mucosa membrane, which can be determined by minimal subjective sensations or even complete absence of clinical manifestations with the formation of “silent ulcers”, complicated by bleeding and perforation.

Keywords: rheumatoid arthritis, NSAIDs, NSAID gastropathies, erosion, ulceration, morphology, erosive-ulcerative lesions.

[1]
Kovalenko VM. Rheumatic diseases: Current trends in pharmacotherapy. Ukrainian J Rheumatol 2009; 37(3): 5-15.
[2]
Roth SH. Nonsteroidal anti-inflammatory drug gastropathy: New avenues for safety. Clin Interv Aging 2011; 6(6): 125-31.
[http://dx.doi.org/10.2147/CIA.S21107] [PMID: 21753867]
[3]
Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metapla-sia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol 2005; 11(6): 791-6.
[http://dx.doi.org/10.3748/wjg.v11.i6.791] [PMID: 15682469]
[4]
Gupta M, Eisen GM. NSAIDs and the gastrointestinal tract. Curr Gastroenterol Rep 2009; 11(5): 345-53.
[http://dx.doi.org/10.1007/s11894-009-0053-z] [PMID: 19765361]
[5]
Dougados M, Simon P, Braun J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical tri-als/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis 2011; 70(2): 249-51.
[http://dx.doi.org/10.1136/ard.2010.133488] [PMID: 20829199]
[6]
Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An american college of rheumatology/european league against rheumatism collaborative initiative. Arthritis Rheum 2010; 62(9): 2569-81.
[http://dx.doi.org/10.1002/art.27584] [PMID: 20872595]
[7]
Svedlund J, Sjödin I, Dotevall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33(2): 129-34.
[http://dx.doi.org/10.1007/BF01535722] [PMID: 3123181]
[8]
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated sydney system. International workshop on the histopathology of gastritis, houston 1994. Am J Surg Pathol 1996; 20(10): 1161-81.
[http://dx.doi.org/10.1097/00000478-199610000-00001] [PMID: 8827022]
[9]
Sapoznikov AG, Dorosevich AE. Histological and microscopical technique: Handbook. Smolensk: SAU 2000.
[10]
Zelickson MS, Bronder CM, Johnson BL, et al. Helicobacter pylori is not the predominant etiology for peptic ulcers requiring operation. Am Surg 2011; 77(8): 1054-60.
[http://dx.doi.org/10.1177/000313481107700827] [PMID: 21944523]
[11]
Zittel TT, Jehle EC, Becker HD. Surgical management of peptic ulcer disease today--indication, technique and outcome. Langenbecks Arch Surg 2000; 385(2): 84-96.
[http://dx.doi.org/10.1007/s004230050250] [PMID: 10796046]
[12]
Kaliberdenko VB, Mametova L, Shanmugaraj K, et al. The effectiveness of treatment of giant gastric and duodenal ulcers with endonasal electrophoresis dalargin (Tyrosyl-d-alanyl-glycyl-phenylalanyl-leucyl-arginine diacetate). Indian J Public Health Res Dev 2019; 10(10): 799-803.
[http://dx.doi.org/10.5958/0976-5506.2019.02915.2]
[13]
Zagari RM, Eusebi LH, Rabitti S, et al. Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects. J Gastroenterol Hepatol 2016; 31(9): 1527-38.
[http://dx.doi.org/10.1111/jgh.13308] [PMID: 26840528]
[14]
Tsujimoto S, Mokuda S, Matoba K, et al. The prevalence of endoscopic gastric mucosal damage in patients with rheumatoid arthritis. PLoS One 2018; 13(7): e0200023.
[http://dx.doi.org/10.1371/journal.pone.0200023] [PMID: 29985937]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy